Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.


Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?


Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Filament Health N.FH

Alternate Symbol(s):  FLHLF

Filament Health Corp is a natural psychedelic drug discovery and extraction technology company. The company's mission is to see safe, approved, natural psychedelics in the hands of everyone who needs them as soon as possible. Filament engages in natural extraction technology commercialization, utilizing its intellectual property portfolio, in-house GMP facility, and Health Canada psilocybin Dealer's License.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 


is it me your looking for  rate and reply

Safe, Natural Psychedelics play worth watching  rate and reply

Neovasc Announces Second Quarter Financial Results

Generated revenues of $818,000, a quarterly record and a year-over-year increase of 29% over the second quarter of 2021. And COSIRA II protocol supplement was approved by the FDA, more than doubling the total number of patients and adding specific patient groups eligible and allowed for treatment in the trial. more


Trial to investigate the effects of Filament's botanical psilocybin drug candidate and Cybin Therapeutics' protocols in treating major depressive disorder in patients taking SSRIs. more

The Power Play by The Market Herald Releases New Interviews

Filament Health has received FDA authorization to initiate the first clinical trial using naturally sourced psychedelic substances. The phase 1 trial will include 20 healthy subjects and examine more

Files 20th Patent Application

Filament has been issued the first patent for the extraction and standardization of natural psilocybin and intends to further develop its IP portfolio VANCOUVER, BC, Sept. 1, 2021 /CNW/ - more

Industry-First Export of Natural GMP Psychedelics to US

The export to the Translational Psychedelic Research Program at UCSF represents an important step in advancing clinical research on natural psilocybin VANCOUVER, BC, Aug. 26, 2021 /CNW/ -& more

to be Issued a Patent for Extraction of Natural Psilocybin

Filament's patent describes the extraction of stable, standardized doses of psychoactive compounds at its Health Canada-licensed, GMP-certified facility VANCOUVER, BC, Aug. 3, 2021 /CNW/ -& more

RE:Nice promo piece.

We are approaching the time when mushrooms sprout up---September  rate and reply

Nice promo piece.  rate and reply